19499001: Carbinoxamine maleate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Ethanolamine derivative antihistamine\Carbinoxamine maleate

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative\Ethanolamine derivative antihistamine\Carbinoxamine maleate

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative\Ethanolamine derivative antihistamine\Carbinoxamine maleate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbinoxamine maleate	Is a	Carbinoxamine (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate	Is a	Carbinoxamine (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate	Has disposition	Histamine receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate	Is modification of (attribute)	Carbinoxamine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate	Is a	Ethanolamine derivative antihistamine	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carbinoxamine maleate 2mg/5mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 4mg/5mL/60mg/5mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/25mg/1mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/5mL/30mg/5mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing carbinoxamine maleate and pseudoephedrine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Carbinoxamine maleate 4 mg oral tablet	Has precise active ingredient	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Carbinoxamine maleate 4 mg oral tablet	Has basis of strength substance (attribute)	True	Carbinoxamine maleate	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32845012	Carbinoxamine maleate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
747687013	Carbinoxamine maleate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
32845012	Carbinoxamine maleate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
32845012	Carbinoxamine maleate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
747687013	Carbinoxamine maleate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
747687013	Carbinoxamine maleate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
24251000188116	carbinoxamine maléate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
797741000172110	maléate de carbinoxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
24251000188116	carbinoxamine maléate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
797741000172110	maléate de carbinoxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module